Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma

Expert Rev Hematol. 2023 Nov 20:1-4. doi: 10.1080/17474086.2023.2285978. Online ahead of print.NO ABSTRACTPMID:37982732 | DOI:10.1080/17474086.2023.2285978

Source: Expert Review of Hematology - November 20, 2023 Category: Hematology Authors: James A Davis Katelynn Granger Alex Sakowski Sara Goodwin Amanda Herbst Deidra Smith Lindsey Hendrickson Victoria R Nachar Source Type: research